Antiva Biosciences, Inc.
New Filing
CIK: 0001563355·Biotechnology·DELAWARE·Filed: Jul 19, 2018
Total Offering
$15,000,000
Amount Sold
$15,000,000
Investors
8
First Sale
Jul 6, 2018
Offering Details
- Type
- Equity, Security to be Acquired
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Gail Maderis | Related Person |
| Michael D. Cannon | Related Person |
| Oranee Daniels | Related Person |
| Raju Gadiraju, Ph.D. | Related Person |
| Wende S. Hutton | Related Person |
| Steven P. James | Related Person |
| Ting Jia | Related Person |
| David Kabakoff, Ph.D. | Related Person |
| Vinzenz Ploerer | Related Person |
| Benjamin Rovinski | Related Person |
| Sarah Walter | Related Person |
Company
SEC Filing
0001563355-18-000001
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free